+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Corticosteroids Therapy Market - Global Forecast 2026-2032- Product Image
Corticosteroids Therapy Market - Global Forecast 2026-2032- Product Image
New

Corticosteroids Therapy Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 185 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5888287
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The corticosteroids therapy market is evolving rapidly as clinical, regulatory, and supply chain trends drive transformation in how these therapies are developed, positioned, and delivered. Senior decision-makers navigating this landscape must consider shifting clinical practices, emerging delivery technologies, and changing global policy, all of which shape long-term commercial strategy.

Market Snapshot

The Corticosteroids Therapy Market grew from USD 5.62 billion in 2025 to USD 6.00 billion in 2026, with a projected CAGR of 8.15% and an expectation to reach USD 9.73 billion by 2032. This robust growth reflects broad clinical use across inflammatory and immune-mediated diseases, increasing therapeutic demand, and proactive adoption of advanced formulations and delivery routes globally. Market expansion is being fueled by innovation in inhaled, oral, topical, and injectable solutions, regulatory focus on safety, and supply chain shifts influenced by policy and trade developments.

Corticosteroids Therapy Market Scope & Segmentation

  • Therapeutic Indications: Addresses a wide range of inflammatory and immune-mediated conditions, including asthma, allergic rhinitis, dermatological disorders, rheumatoid arthritis, and inflammatory bowel disease.
  • Administration Routes: Includes inhaled (dry powder inhalers, metered dose inhalers, nebulizers), oral (tablet, suspension), topical (cream, lotion, ointment), and injectable (intramuscular, intravenous, subcutaneous) options.
  • Drug Types: Encompasses budesonide, dexamethasone, hydrocortisone, methylprednisolone, and prednisone, each distinguished by potency, duration of action, and receptor affinity.
  • Dosage Forms: Coverage includes tablets, suspensions, injections, creams, lotions, and ointments, supporting both acute rescue and chronic disease management.
  • Patient Demographics: Solutions are tailored for adult, geriatric, and pediatric populations, with distinct safety monitoring and dosing protocols for each group.
  • Geographies: Analyzes regional dynamics across the Americas, Europe, Middle East & Africa (EMEA), and Asia-Pacific, reflecting differing regulatory climates, access landscapes, and manufacturing capabilities.
  • Technology & Innovation: Considers advances in formulation science, delivery devices, and digital support tools, enabling precision therapy and improved patient adherence.

Key Takeaways for Decision-Makers

  • New formulation approaches—including targeted inhalers and enhanced topical options—are expanding the therapeutic applications and reducing systemic risks.
  • Regulatory changes place greater emphasis on stewardship, encouraging protocols that minimize cumulative steroid exposure and foster prescriber adherence to updated guidance.
  • Supply chain strategies are adapting, with increased focus on sourcing diversity, nearshoring, and operational resilience to withstand tariff adjustments and import dependencies.
  • Segmented market approaches, considering route of administration and patient group, enable precise alignment between clinical needs, product design, and service delivery.
  • Commercial leadership depends increasingly on value-added services such as patient adherence support, device training, and real-world evidence generation.
  • Differentiated R&D and partnership models are driving the development of combination therapies, device-enabled solutions, and targeted lifecycle management initiatives.

Tariff Impact on Supply Chain Continuity

In 2025, United States tariff adjustments have significantly influenced corticosteroid supply chains by introducing new complexities for manufacturers relying on cross-border APIs, excipients, and specialized packaging. These policy shifts are prompting companies to revisit procurement, diversify supplier portfolios, and strengthen logistical planning to ensure uninterrupted therapy delivery. To address potential disruptions, organizations are implementing scenario-based planning, enhancing transparency across supplier tiers, and reinforcing contractual safeguards. Reliable access to therapies is critical, with any supply interruption potentially affecting dosing, patient monitoring, and continuity of care.

Methodology & Data Sources

This analysis employs a mixed-methods approach, synthesizing peer-reviewed literature, regulatory documentation, relevant supply chain records, and insights from stakeholders including clinicians and industry experts. Analytical frameworks ensure transparent comparison of formulations, delivery routes, and operational factors, with cross-validation used to enhance accuracy and reduce bias.

Why This Report Matters

  • Enables market leaders to make informed choices in product development, supply chain design, and regional commercial strategy based on reliable evidence and precise segmentation.
  • Supports clinical and operational teams with actionable intelligence on evolving regulatory, technological, and therapeutic trends impacting corticosteroid therapy optimization.
  • Provides a strategic roadmap for sustaining therapeutic impact and agility amid changing global policy and healthcare delivery models.

Conclusion

Organizations that align targeted formulation innovation, evidence-driven safety practices, and supply chain resilience are best positioned for success. Leaders can leverage these insights for strategic decision-making, ongoing operational excellence, and robust patient-centered care in the dynamic corticosteroids therapy sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Corticosteroids Therapy Market, by Drug Type
8.1. Budesonide
8.2. Dexamethasone
8.3. Hydrocortisone
8.4. Methylprednisolone
8.5. Prednisone
9. Corticosteroids Therapy Market, by Route Of Administration
9.1. Inhalation
9.1.1. Dry Powder Inhaler
9.1.2. Metered Dose Inhaler
9.1.3. Nebulizer
9.2. Injectable
9.2.1. Intramuscular
9.2.2. Intravenous
9.2.3. Subcutaneous
9.3. Oral
9.3.1. Suspension
9.3.2. Tablet
9.4. Topical
9.4.1. Cream
9.4.2. Lotion
9.4.3. Ointment
10. Corticosteroids Therapy Market, by Dosage Form
10.1. Cream
10.2. Injection
10.3. Suspension
10.4. Tablet
11. Corticosteroids Therapy Market, by Indication
11.1. Allergic Rhinitis
11.2. Asthma
11.3. Dermatological Disorders
11.4. Inflammatory Bowel Disease
11.5. Rheumatoid Arthritis
12. Corticosteroids Therapy Market, by Patient Age Group
12.1. Adult
12.2. Geriatric
12.3. Pediatric
13. Corticosteroids Therapy Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Corticosteroids Therapy Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Corticosteroids Therapy Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Corticosteroids Therapy Market
17. China Corticosteroids Therapy Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Abbott Laboratories
18.6. Allergan PLC by AbbVie Inc.
18.7. Amgen Inc.
18.8. AstraZeneca PLC
18.9. Biogen Inc.
18.10. Boehringer Ingelheim GmbH
18.11. Bristol-Myers Squibb Company
18.12. Cipla Inc.
18.13. Dr. Reddy's Laboratories Ltd.
18.14. Eli Lilly and Company
18.15. Galderma Group
18.16. Gilead Sciences, Inc.
18.17. GlaxoSmithKline PLC
18.18. Lupin Pharmaceuticals, Inc.
18.19. Merck & Co., Inc.
18.20. Mylan N.V.
18.21. Novartis AG
18.22. Pfizer Inc.
18.23. Sanofi S.A.
18.24. SANTHERA PHARMACEUTICALS
18.25. Sun Pharmaceutical Industries Ltd.
18.26. Takeda Pharmaceutical Company Limited
18.27. Teva Pharmaceutical Industries Ltd.
List of Figures
FIGURE 1. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL CORTICOSTEROIDS THERAPY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL CORTICOSTEROIDS THERAPY MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES CORTICOSTEROIDS THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA CORTICOSTEROIDS THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY BUDESONIDE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY BUDESONIDE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY BUDESONIDE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY DEXAMETHASONE, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY DEXAMETHASONE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY DEXAMETHASONE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY HYDROCORTISONE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY HYDROCORTISONE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY HYDROCORTISONE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY METHYLPREDNISOLONE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY METHYLPREDNISOLONE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY METHYLPREDNISOLONE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY PREDNISONE, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY PREDNISONE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY PREDNISONE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRY POWDER INHALER, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRY POWDER INHALER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRY POWDER INHALER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY METERED DOSE INHALER, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY METERED DOSE INHALER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY METERED DOSE INHALER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY NEBULIZER, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY NEBULIZER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY NEBULIZER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INTRAMUSCULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INTRAMUSCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY SUBCUTANEOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY SUBCUTANEOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY SUSPENSION, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY SUSPENSION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY SUSPENSION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY TABLET, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY TABLET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY TABLET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY CREAM, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY CREAM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY CREAM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY LOTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY LOTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY LOTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY OINTMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY OINTMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY OINTMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY CREAM, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY CREAM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY CREAM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY SUSPENSION, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY SUSPENSION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY SUSPENSION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY TABLET, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY TABLET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY TABLET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY ALLERGIC RHINITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY ALLERGIC RHINITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY ALLERGIC RHINITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY ASTHMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY ASTHMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY ASTHMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY DERMATOLOGICAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY DERMATOLOGICAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY DERMATOLOGICAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. AMERICAS CORTICOSTEROIDS THERAPY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 109. AMERICAS CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 110. AMERICAS CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 111. AMERICAS CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 112. AMERICAS CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 113. AMERICAS CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 114. AMERICAS CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 115. AMERICAS CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 116. AMERICAS CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 117. AMERICAS CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 118. NORTH AMERICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. NORTH AMERICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 120. NORTH AMERICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 121. NORTH AMERICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 122. NORTH AMERICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 123. NORTH AMERICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 124. NORTH AMERICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 125. NORTH AMERICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 126. NORTH AMERICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 127. NORTH AMERICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 128. LATIN AMERICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. LATIN AMERICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 130. LATIN AMERICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 131. LATIN AMERICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 132. LATIN AMERICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 133. LATIN AMERICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 134. LATIN AMERICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 135. LATIN AMERICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 136. LATIN AMERICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 137. LATIN AMERICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 148. EUROPE CORTICOSTEROIDS THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 149. EUROPE CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 150. EUROPE CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 151. EUROPE CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 152. EUROPE CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 153. EUROPE CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 154. EUROPE CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 155. EUROPE CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 156. EUROPE CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 157. EUROPE CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 158. MIDDLE EAST CORTICOSTEROIDS THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 159. MIDDLE EAST CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 160. MIDDLE EAST CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 161. MIDDLE EAST CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 162. MIDDLE EAST CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 163. MIDDLE EAST CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 164. MIDDLE EAST CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 165. MIDDLE EAST CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 166. MIDDLE EAST CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 167. MIDDLE EAST CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 168. AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 169. AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 170. AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 171. AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 172. AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 173. AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 174. AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 175. AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 176. AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 177. AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 178. ASIA-PACIFIC CORTICOSTEROIDS THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 179. ASIA-PACIFIC CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 180. ASIA-PACIFIC CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 181. ASIA-PACIFIC CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 182. ASIA-PACIFIC CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 183. ASIA-PACIFIC CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 184. ASIA-PACIFIC CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 185. ASIA-PACIFIC CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 186. ASIA-PACIFIC CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 187. ASIA-PACIFIC CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 188. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 189. ASEAN CORTICOSTEROIDS THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. ASEAN CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 191. ASEAN CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 192. ASEAN CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 193. ASEAN CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 194. ASEAN CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 195. ASEAN CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 196. ASEAN CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 197. ASEAN CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 198. ASEAN CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 199. GCC CORTICOSTEROIDS THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 200. GCC CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 201. GCC CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 202. GCC CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 203. GCC CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 204. GCC CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 205. GCC CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 206. GCC CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 207. GCC CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 208. GCC CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 209. EUROPEAN UNION CORTICOSTEROIDS THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 210. EUROPEAN UNION CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 211. EUROPEAN UNION CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 212. EUROPEAN UNION CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 213. EUROPEAN UNION CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 214. EUROPEAN UNION CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 215. EUROPEAN UNION CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 216. EUROPEAN UNION CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 217. EUROPEAN UNION CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 218. EUROPEAN UNION CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 219. BRICS CORTICOSTEROIDS THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 220. BRICS CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 221. BRICS CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 222. BRICS CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 223. BRICS CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 224. BRICS CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 225. BRICS CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 226. BRICS CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 227. BRICS CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 228. BRICS CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 229. G7 CORTICOSTEROIDS THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 230. G7 CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 231. G7 CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 232. G7 CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 233. G7 CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 234. G7 CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 235. G7 CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 236. G7 CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 237. G7 CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 238. G7 CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 239. NATO CORTICOSTEROIDS THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 240. NATO CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 241. NATO CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 242. NATO CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 243. NATO CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 244. NATO CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 245. NATO CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 246. NATO CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 247. NATO CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 248. NATO CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 249. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 250. UNITED STATES CORTICOSTEROIDS THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 251. UNITED STATES CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 252. UNITED STATES CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 253. UNITED STATES CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 254. UNITED STATES CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 255. UNITED STATES CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 256. UNITED STATES CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 257. UNITED STATES CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 258. UNITED STATES CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 259. UNITED STATES CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 260. CHINA CORTICOSTEROIDS THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 261. CHINA CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 262. CHINA CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 263. CHINA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 264. CHINA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 265. CHINA CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 266. CHINA CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 267. CHINA CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 268. CHINA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 269. CHINA CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Corticosteroids Therapy market report include:
  • Abbott Laboratories
  • Allergan PLC by AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca PLC
  • Biogen Inc.
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb Company
  • Cipla Inc.
  • Dr. Reddy's Laboratories Ltd.
  • Eli Lilly and Company
  • Galderma Group
  • Gilead Sciences, Inc.
  • GlaxoSmithKline PLC
  • Lupin Pharmaceuticals, Inc.
  • Merck & Co., Inc.
  • Mylan N.V.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi S.A.
  • SANTHERA PHARMACEUTICALS
  • Sun Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries Ltd.

Table Information

Report AttributeDetails
No. of Pages185
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 6 Billion
Forecasted Market Value ( USD ) by 2032 $ 9.73 Billion
Compound Annual Growth Rate8.1%
Regions CoveredGlobal
No. of Companies Mentioned24

Related Topics

Related Reports

Corticosteroids Inhalation Formulation Market - Global Forecast 2026-2032 - Product Image

Corticosteroids Inhalation Formulation Market - Global Forecast 2026-2032

  • Report
  • 185 Pages
  • Global
From
Adrenal Corticosteroid Inhibitors Market - Global Forecast 2026-2032 - Product Image

Adrenal Corticosteroid Inhibitors Market - Global Forecast 2026-2032

  • Report
  • 195 Pages
  • Global
From
Corticosteroids Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Corticosteroids Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 181 Pages
  • Global
From
Corticosteroids Therapy - Global Strategic Business Report - Product Image

Corticosteroids Therapy - Global Strategic Business Report

  • Report
  • 282 Pages
  • Global
From
Corticosteroid API Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Corticosteroid API Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From

About the Corticosteroid Market

The Corticosteroid market is a segment of the Healthcare Services industry that focuses on the production and distribution of corticosteroid drugs. Corticosteroids are a class of drugs used to treat a variety of conditions, including allergies, asthma, and autoimmune diseases. They are also used to reduce inflammation and swelling. Corticosteroids are available in both oral and injectable forms, and are often prescribed in combination with other medications. The Corticosteroid market is highly competitive, with a number of large pharmaceutical companies producing and distributing these drugs. Companies in the market are focused on developing new formulations and delivery systems to improve patient outcomes. They are also investing in research and development to create new treatments for a variety of conditions. Some of the major companies in the Corticosteroid market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and Novartis. These companies are involved in the production, distribution, and marketing of corticosteroid drugs. They are also involved in research and development to create new treatments and formulations. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.